Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients

Diabetes and Metabolism

Volumn 26, Issue 2, 2000, Pages 107-112

  Ribault, A ^b   Durou, M R ^c   Letellier, C ^c   Wojcik, F ^c   Poirier, J Y ^a   Ruelland, A ^c  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Laboratoire de Biochimie A   (France)

^c NONE

Author keywords

Apo(a) phenotypes; Type 1 diabetes; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; FEMALE; HUMAN; IMMUNOBLOTTING; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; APOPROTEIN(A); DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOBLOTTING; LIPOPROTEIN(A); MALE; MIDDLE AGED; MOLECULAR WEIGHT; PHENOTYPE; PROTEIN ISOFORMS; REFERENCE VALUES;

EID: 0034075464     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Utermann GH, Menzel J, Kraft HG. Lp(a) glycoprotein phenotypes: Inherance and relation to Lp(a) lipoprotein concentrations in plasma. J Clin Invest, 1987, 80, 458-465.
2. National diabetes data group. Classification and diagnostic of diabetes mellitus and other categories of glucose tolerance. Diabetes, 1979, 38, 183-185.
3. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholestérol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972, 18, 499-502.
4. Laurell CB.Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Ann Biochem, 1966, 15, 45-52.
5. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson G, Boerwinkle E, Uterman G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med, 1990, 322, 1494-1499.
6. Utermann GH, Kraft G, Menzel HJ, Hopferwieser T, Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet, 1988, 78, 41-46.
7. Utermann GH, Duba C, Menzel HJ. Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet, 1988, 78, 47-50.
8. Brewer HB. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In: Lipoprotein(a). Ed. Academic Press Inc. San Diego, 1990, 211-220.
9. Dart A, Jerums G, Nicholson G, D'Emden M et al. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol, 1997, 80, 39-44.
10. Delambre C, Ruelland A, Le Guerrier A-M, Lorcy Y, Cloarec L, Allannic H. Lipoprotéine (a), risque vasculaire et diabete insulino-dependant. Rev Franc Endocrinol Clin, 1992, 33, 43-50.
11. Heller Fr, Jamart J, Honore P et al. Serum lipoprotein (a) in patients with diabetes mellitus. Diabetes Care, 1993, 16, 819-823.
12. Durlach V, Gillery P, Bertin E, Grulet H, Gross A, Leutenegger M. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients. Diabetes Metab, 1998, 23, 124-130.
13. Ruiz J, Thillet J, Huby T et al. Association of elevated lipoproiein (a) levels and coronary heart disease in NIDDM patients. Relationship with apo(a) phenotypes. Diabetologia, 1994, 37, 585-591.
14. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R. The relation of Lp(a) concentrations and apo(a) phenotypes with asymptomatic atherosclerosis in subjects of the atherosclerosis risk in communities (ARIC) study. Arterioscl Thromb. 1993, 13, 1558-1566.
15. Mezdour H, Parra HJ, Aguie G, Fruchart JC. La lipoprotéine(a): Un marqueur additionnel de l'athérosclérose. Ann Biol Clin, 1990, 48, 139-153.
16. Albers JJ, Whal P, Hazzard WR. Quantitative genetic studies of the human plasma Lp(a) lipoprotein. Bioch Genet, 1974, 6, 475-478.
17. Duriez P, Fruchart JC. La lipoprotéine (a): Facteur de risque cardio-vasculaire?. Spectra Biol. 1995, 1, 33-40.
18. Gaw A, Boerwinkle E, Cohen JC, Hobbs H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. J Clin Invest, 1994, 93, 2526-2534.
19. Gazzaruso C, Garzaniti A, Buscaglia P, D'Annunzio G, Porta A, Vandelli G, Lorini R, Finardi G, Fratino P, Geroldi D. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta-Diabetol, 1998, 35, 13-18.
20. Csàszàr A, Dieplinger H, Sandholzer C el al. Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia, 1993, 36, 47-51.
21. Linden T, Taddei-Peters W, Wilhelmsen L, Herlitz J, Karlsson T, Ullstrom C, Wiklund O. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery. Atherosclerosis. 1998, 137, 175-186.
22. Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, Konig P. Elevated plasma concentrations of lipoprotein (a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein (a). J Clin Invest, 1993, 91, 397-401.